Now showing items 1-2 of 2
Plerixafor for pbsc mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from europe and the usa
(Springer Nature, 2011-02-28)
We describe 20 patients with myeloma and 1 with primary amyloidosis from 15 centres, all with advanced renal failure, most of whom had PBSC mobilised using plerixafor following previous failed mobilisation by conventional ...
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Elacytarabine is a novel cytotoxic nucleoside analogue, independent of nucleoside transporters (e.g. human Equilibrative Nucleoside Transporter 1 [hENT1]) for cell uptake, and mechanisms of action similar to those of ...